Adalimumab Biosimilar–Induced Autoimmunity-Related Sweet-Like Neutrophilic Dermatosis-Reference-Cited by-同舟云学术

Adalimumab Biosimilar–Induced Autoimmunity-Related Sweet-Like Neutrophilic Dermatosis

Published:2023-01-10 Issue:3 Volume:45 Page:176-179
ISSN:0193-1091
Container-title:The American Journal of Dermatopathology
language:en
Short-container-title:

Author:

Lobato-Berezo Alejandro¹,Pujol Ramon M.²,Fernández-Figueras María Teresa²

Affiliation:

1. Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain; and

2. Department of Pathology, Hospital Universitario General de Catalunya, Sant Cugat del Vallès, Barcelona, Spain.

Abstract

Abstract: Antitumor necrosis factor therapies have shown to produce a broad range of cutaneous eruptions. We report the case of a patient under adalimumab biosimilar treatment for a punctate inner choroidopathy who developed a cutaneous eruption on sun-exposed areas that showed a diffuse dermal neutrophilic infiltrate consistent with a Sweet-like neutrophilic dermatosis and some features of autoimmunity.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Dermatology,General Medicine,Pathology and Forensic Medicine

Reference16 articles.

1. Adalimumab-induced lupus erythematosus;Al-Niaimi;Eur J Dermatol.,2009

2. Broad range of adverse cutaneous eruptions in patients on TNF-alpha antagonists;Hawryluk;J Cutan Pathol.,2012

3. Sweet's syndrome in a patient with seropositive rheumatoid arthritis after starting adalimumab: is sweet's syndrome related to rheumatoid arthritis or is it the paradoxical effect of adalimumab?;Paul;Cureus,2021

4. Sweet syndrome, not so Sweet during an ulcerative colitis flare especially when you cannot eat;Stead;Case Rep Gastrointest Med.,2021

5. Successful management of tumor necrosis factor-alpha inhibitor-induced Sweet syndrome in a patient with ulcerative colitis: a case report;Chang;Int J Clin Pharmacol Ther.,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adalimumab;Reactions Weekly;2023-07-15